Current Management of Thrombocytopenia in Chronic Liver Disease

Overview

Journal Gastroenterol Hepatol (N Y)

Specialty Gastroenterology

Date 2019 May 8

PMID 31061657

Citations 5

Authors

Robert S Brown Jr

Affiliations

Soon will be listed here.

Citing Articles

Estimation of the Eligible Population For Resmetirom Among Adults in the United States for Treatment of Non-Cirrhotic NASH with Moderate-to-Advanced Liver Fibrosis.

Fishman J, Kim Y, Charlton M, Smith Z, OConnell T, Bercaw E Adv Ther. 2024; 41(11):4172-4190.

PMID: 39292422 PMC: 11480167. DOI: 10.1007/s12325-024-02989-5.

The Prognostic Significance of the Platelet Count in Alcoholic Hepatitis.

Birnbaum J, Herman H, Gao Q, Koenigsberg M, Sigal S Gastro Hep Adv. 2024; 2(1):8-15.

PMID: 39130158 PMC: 11308416. DOI: 10.1016/j.gastha.2022.07.022.

Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures.

Flisiak R, Antonov K, Drastich P, Jarcuska P, Maevskaya M, Makara M J Clin Med. 2021; 10(22).

PMID: 34830701 PMC: 8625449. DOI: 10.3390/jcm10225419.

Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management.

Scharf R J Clin Med. 2021; 10(7).

PMID: 33917431 PMC: 8038677. DOI: 10.3390/jcm10071530.

Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China.

Song J, Liu S, Zhu F, Wen A, Ma L, Li W Mil Med Res. 2020; 7(1):15.

PMID: 32241296 PMC: 7118900. DOI: 10.1186/s40779-020-00244-w.

References

Brown Jr R . Review article: a pharmacoeconomic analysis of thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther. 2007; 26 Suppl 1:41-8. DOI: 10.1111/j.1365-2036.2007.03505.x. View

Giannini E, Greco A, Marenco S, Andorno E, Valente U, Savarino V . Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. Clin Gastroenterol Hepatol. 2010; 8(10):899-902. DOI: 10.1016/j.cgh.2010.06.018. View

Kim E . Lusutrombopag: First Global Approval. Drugs. 2015; 76(1):155-8. DOI: 10.1007/s40265-015-0525-4. View

Peck-Radosavljevic M . Thrombocytopenia in chronic liver disease. Liver Int. 2016; 37(6):778-793. DOI: 10.1111/liv.13317. View

Terrault N, Chen Y, Izumi N, Kayali Z, Mitrut P, Tak W . Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia. Gastroenterology. 2018; 155(3):705-718. DOI: 10.1053/j.gastro.2018.05.025. View